Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial.
評估 empagliflozin 在接受經皮冠狀動脈介入治療患者中預防心肌損傷的效果:一項雙盲隨機臨床試驗。
J Cardiovasc Thorac Res 2024-09-10
The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial.
EMPAGliflozin對合併型2糖尿病和冠狀動脈疾病患者炎症標誌的影響:EMPA-CARD隨機對照試驗。
Diabetol Metab Syndr 2022-11-21
Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial.
Empagliflozin和colchicine在ST段抬高型心肌梗塞後左心室射血分數降低患者中的應用:一項隨機、雙盲、三臂平行對照組控制試驗。
Eur J Clin Pharmacol 2024-02-06
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
Empagliflozin對急性心肌梗塞後心衰結果的影響:來自EMPACT-MI試驗的洞察。
Circulation 2024-04-06
Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after coronary artery bypass grafting: a double-blind, randomized, placebo-controlled trial.
冠狀動脈旁路移植術後 empagliflozin 預防心房纖維顫動效果的評估:雙盲、隨機、安慰劑對照試驗。
Naunyn Schmiedebergs Arch Pharmacol 2024-07-02
The effect of Empagliflozin on echocardiographic parameters in diabetic patients after acute myocardial infarction: A systematic review and meta-analysis with trial sequential analysis.
糖尿病患者急性心肌梗塞後 Empagliflozin 對心臟超聲波參數的影響:一項系統性回顧和具有試驗序列分析的荟萃分析。
Ir J Med Sci 2024-07-03
Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial.
Empagliflozin對心肌梗塞事件總數的影響及類型和其他冠狀動脈結果:來自隨機的EMPA-REG OUTCOME試驗的洞察。
Cardiovasc Diabetol 2024-07-11